IFNG and neoplasm: It has been reported that the suppression of antitumour immunity is associated with the pro-tumoral effect of PEGylated liposomal doxorubicin (PLD).131 PLD reduces IFN-γ production by TAMs and cytotoxic T lymphocytes which is essential for anti-tumour immunity.